FDAnews
www.fdanews.com/articles/198915-inovio-taps-thermo-fisher-scientific-to-manufacture-covid-19-vaccine
Thermo Fisher logo

Inovio Taps Thermo Fisher Scientific to Manufacture COVID-19 Vaccine

September 9, 2020

Inovio on Tuesday announced that Thermo Fisher Scientific has signed a letter of intent to manufacture Inovio’s COVID-19 vaccine candidate INO-4800. 

Under the agreement, Thermo Fisher will manufacture the drug substance for the vaccine as well as perform fill and finish at its U.S. facilities. The company expects to produce at least 100 million doses of the vaccine annually.

Inovio has previously signed COVID-19 vaccine manufacturing agreements with Richter-Helm BioLogics and Ology Biosciences. 

View today's stories